Xpert® vanA/vanB 45-Minutes, Screen, detect, prevent, An accurate, rapid test to identity patients colonized with vancomycin-resistant enterococci (VRE). ^Ce C€ m In Vitro Diagnostic Medical Device A better way.

THE NEED VRE: A growing concern Data from the European Antimicrobial Resistance Surveillance System indicates that infection rates with VRE are increasing, particularly in countries with high MRSA prevalence.2 • The proportion of invasive vancomycin-resistant Enterococcus faecium isolates reached 17% in Greece, 44% in Ireland, 23% in Portugal, 13% in the UK, and 16% in Germany2 • The percentage of vancomycin-resistant E. faecalis isolates from healthcare-associated infections varies from 4.2% in Spain to 17.8% in Portugal2 CDC, SHEA and WHO have put forward the following guidelines on how to...

© THE IMPACT With the GeneXpert® System you get both speed and accuracy in a single test cartridge. By providing the most efficient PCR test for VRE you will accelerate your laboratory's workflow with on-demand, random-access flexibility. Combining performance with the ability to run other tests (GBS, MRSA, C. difficile, Flu, etc.) will give you proven efficiency by having true menu consolidation on only one instrument, with less than 1 minute of hands-on time and actionable results in 45 minutes. Shift your lab from reactive to proactive • Receive a rapid result allowing for same day containment...

3 EASY STEPS Total hands-on time: <1 Minute Insert swab into Sample Reagent vial and break Vortex and dispense Sample into Port S 3 Insert cartridge and start assay Xpert® vanA/vanB is a qualitative in vitro diagnostic test designed for rapid detection of vancomycin-resistance (vanA/vanB) genes. CATALOG NUMBER Xpert vanA/vanB (10 tests) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . GXVANA/B-CE-10 References: 1. Birgand G, et al. Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs. Antimicrob Resist...